Cargando…

Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial

OBJECTIVE: The objective was to evaluate the effects of transcutaneous acupoint electric stimulation (TAES) and gastric electrical stimulation (GES) on cancer patients with chemotherapy-induced gastrointestinal (GI) symptoms. METHODS: A total of 122 lung cancer patients receiving chemotherapy were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Ting, Cheng, Qinqin, Liu, Xiangyu, Chen, Yongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030592/
https://www.ncbi.nlm.nih.gov/pubmed/33850958
http://dx.doi.org/10.4103/apjon.apjon_61_20
_version_ 1783676116179877888
author Mao, Ting
Cheng, Qinqin
Liu, Xiangyu
Chen, Yongyi
author_facet Mao, Ting
Cheng, Qinqin
Liu, Xiangyu
Chen, Yongyi
author_sort Mao, Ting
collection PubMed
description OBJECTIVE: The objective was to evaluate the effects of transcutaneous acupoint electric stimulation (TAES) and gastric electrical stimulation (GES) on cancer patients with chemotherapy-induced gastrointestinal (GI) symptoms. METHODS: A total of 122 lung cancer patients receiving chemotherapy were assigned randomly to the following two groups: control group (usual care group, n = 61) and intervention group (TAES plus GES, n = 61). TAES involved two acupoints such as Neiguan (PC6) and Zusanli (ST36). GES was performed at gastric pacing sites on the body surface such as the places of projection of gastric antrum and corpus on the body surface. GES was performed on these sites for 14 days continuously (25 min every time, once daily). The effects of TAES and GES on GI symptoms were assessed using the Memorial Symptom Assessment Scale on the day prior to chemotherapy (time point 1) and days 14 (time point 2) and 28 (time point 3) after chemotherapy. RESULTS: No significant differences in the demographic and disease-related variables were detected between the two groups. Differences in symptom occurrence and severity at time point 1 were not statistically significant between the two groups (both P > 0.05). At time points 2 and 3, GI symptoms such as loss of appetite, nausea, vomiting, diarrhea, and constipation in the stimulation group had statistically significantly improved compared with the control group (all P < 0.05). CONCLUSIONS: TAES and GES were efficacious in relieving GI discomfort in lung cancer patients after chemotherapy. TAES combined with GES is a safe and easy-to-use tool to manage GI symptoms in practice.
format Online
Article
Text
id pubmed-8030592
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80305922021-04-12 Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial Mao, Ting Cheng, Qinqin Liu, Xiangyu Chen, Yongyi Asia Pac J Oncol Nurs Original Article OBJECTIVE: The objective was to evaluate the effects of transcutaneous acupoint electric stimulation (TAES) and gastric electrical stimulation (GES) on cancer patients with chemotherapy-induced gastrointestinal (GI) symptoms. METHODS: A total of 122 lung cancer patients receiving chemotherapy were assigned randomly to the following two groups: control group (usual care group, n = 61) and intervention group (TAES plus GES, n = 61). TAES involved two acupoints such as Neiguan (PC6) and Zusanli (ST36). GES was performed at gastric pacing sites on the body surface such as the places of projection of gastric antrum and corpus on the body surface. GES was performed on these sites for 14 days continuously (25 min every time, once daily). The effects of TAES and GES on GI symptoms were assessed using the Memorial Symptom Assessment Scale on the day prior to chemotherapy (time point 1) and days 14 (time point 2) and 28 (time point 3) after chemotherapy. RESULTS: No significant differences in the demographic and disease-related variables were detected between the two groups. Differences in symptom occurrence and severity at time point 1 were not statistically significant between the two groups (both P > 0.05). At time points 2 and 3, GI symptoms such as loss of appetite, nausea, vomiting, diarrhea, and constipation in the stimulation group had statistically significantly improved compared with the control group (all P < 0.05). CONCLUSIONS: TAES and GES were efficacious in relieving GI discomfort in lung cancer patients after chemotherapy. TAES combined with GES is a safe and easy-to-use tool to manage GI symptoms in practice. Wolters Kluwer - Medknow 2021-02-04 /pmc/articles/PMC8030592/ /pubmed/33850958 http://dx.doi.org/10.4103/apjon.apjon_61_20 Text en Copyright: © 2021 Ann & Joshua Medical Publishing Co. Ltd https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mao, Ting
Cheng, Qinqin
Liu, Xiangyu
Chen, Yongyi
Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title_full Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title_fullStr Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title_full_unstemmed Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title_short Effect of Electrical Stimulation on Gastrointestinal Symptoms in Lung Cancer Patients during Chemotherapy: A Randomized Controlled Trial
title_sort effect of electrical stimulation on gastrointestinal symptoms in lung cancer patients during chemotherapy: a randomized controlled trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030592/
https://www.ncbi.nlm.nih.gov/pubmed/33850958
http://dx.doi.org/10.4103/apjon.apjon_61_20
work_keys_str_mv AT maoting effectofelectricalstimulationongastrointestinalsymptomsinlungcancerpatientsduringchemotherapyarandomizedcontrolledtrial
AT chengqinqin effectofelectricalstimulationongastrointestinalsymptomsinlungcancerpatientsduringchemotherapyarandomizedcontrolledtrial
AT liuxiangyu effectofelectricalstimulationongastrointestinalsymptomsinlungcancerpatientsduringchemotherapyarandomizedcontrolledtrial
AT chenyongyi effectofelectricalstimulationongastrointestinalsymptomsinlungcancerpatientsduringchemotherapyarandomizedcontrolledtrial